Works matching IS 00071048 AND DT 2022 AND VI 198 AND IP 3
Results: 30
Erratum.
- Published in:
- 2022
- Publication type:
- Correction Notice
Corrigendum.
- Published in:
- 2022
- Publication type:
- Correction Notice
GOALs in relapsed DLBCL.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 419, doi. 10.1111/bjh.18296
- By:
- Publication type:
- Article
Haematological variables and risk of future venous thromboembolism in the British Regional Heart Study on men. Combined D‐dimer and APTT as a predictive test for thromboembolism?
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 587, doi. 10.1111/bjh.18288
- By:
- Publication type:
- Article
Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 574, doi. 10.1111/bjh.18287
- By:
- Publication type:
- Article
T‐helper cell regulation of CD45 phosphatase activity by galectin‐1 and CD43 governs chronic lymphocytic leukaemia proliferation.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 556, doi. 10.1111/bjh.18285
- By:
- Publication type:
- Article
Identification of seasonal variation in the diagnosis of acute myeloid leukaemia: a population‐based study.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 545, doi. 10.1111/bjh.18279
- By:
- Publication type:
- Article
Myeloid neoplasms with 8q24/MYC rearrangement are frequently associated with myelodysplasia, complex karyotype, TP53 alterations, and inferior survival.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 604, doi. 10.1111/bjh.18278
- By:
- Publication type:
- Article
Highly sensitive droplet digital polymerase chain reaction for BCR::ABL1 messenger RNA identifies patients with chronic myeloid leukaemia with a low probability of achieving treatment‐free remission.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 600, doi. 10.1111/bjh.18277
- By:
- Publication type:
- Article
Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. e46, doi. 10.1111/bjh.18274
- By:
- Publication type:
- Article
Minimal residual disease and imaging‐guided consolidation strategies in newly diagnosed and relapsed refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 515, doi. 10.1111/bjh.18249
- By:
- Publication type:
- Article
Antibody responses to SARS‐CoV‐2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti‐cancer therapies.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 478, doi. 10.1111/bjh.18248
- By:
- Publication type:
- Article
Enhancing our chances of picking a winner in higher‐risk myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 415, doi. 10.1111/bjh.18240
- By:
- Publication type:
- Article
Thrombophilia testing: A British Society for Haematology guideline.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 443, doi. 10.1111/bjh.18239
- By:
- Publication type:
- Article
Limited value of the D‐dimer based YEARS algorithm to rule out pulmonary embolism in sickle cell disease and sickle cell trait.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. e42, doi. 10.1111/bjh.18237
- By:
- Publication type:
- Article
Characteristics, management and outcome of acquired amegakaryocytic thrombocytopenia.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 595, doi. 10.1111/bjh.18235
- By:
- Publication type:
- Article
Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. e38, doi. 10.1111/bjh.18234
- By:
- Publication type:
- Article
Hypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. e35, doi. 10.1111/bjh.18229
- By:
- Publication type:
- Article
Cerebral nocardiosis in ibrutinib‐treated chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 414, doi. 10.1111/bjh.18227
- By:
- Publication type:
- Article
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher‐Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 535, doi. 10.1111/bjh.18193
- By:
- Publication type:
- Article
The use of next‐generation sequencing in the diagnosis of rare inherited anaemias: A Joint BSH/EHA Good Practice Paper*.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 459, doi. 10.1111/bjh.18191
- By:
- Publication type:
- Article
Acute myeloid leukaemia with double minute chromosomes encompassing the 8q24 region.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 413, doi. 10.1111/bjh.18223
- By:
- Publication type:
- Article
A national service for delivering CD19 CAR‐Tin large B‐cell lymphoma – The UK real‐world experience.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 492, doi. 10.1111/bjh.18209
- By:
- Publication type:
- Article
A randomised comparison of FLAG‐Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 528, doi. 10.1111/bjh.18195
- By:
- Publication type:
- Article
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 482, doi. 10.1111/bjh.18161
- By:
- Publication type:
- Article
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome‐negative B‐precursor acute lymphoblastic leukaemia in first relapse.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 523, doi. 10.1111/bjh.18218
- By:
- Publication type:
- Article
Real‐world data on prognostic value of measurable residual disease assessment by fragment analysis or next‐generation sequencing in multiple myeloma.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 503, doi. 10.1111/bjh.18211
- By:
- Publication type:
- Article
Bone health and glucocorticoid‐containing lymphoma therapy — a review of risk factors and preventative measures.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 431, doi. 10.1111/bjh.18104
- By:
- Publication type:
- Article
Orthopaedic adverse events among adolescents and adults treated with asparaginase for acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 421, doi. 10.1111/bjh.18093
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 409, doi. 10.1111/bjh.17597
- Publication type:
- Article